Forte Biosciences (FBRX) Current Leases (2019 - 2020)
Forte Biosciences (FBRX) reported Current Leases of $435000.0 for Q1 2020, down 45.35% year-over-year from $796000.0 in Q2 2019, and up 4.57% quarter-over-quarter from $416000.0 in Q4 2019.
Forte Biosciences (FBRX) Current Leases (2019 - 2020) Analysis & Trends
Forte Biosciences (FBRX) has 2 years of Current Leases data on file, last reported at $435000.0 in Q1 2020.
- Current Leases for Q1 2020 came in at $435000.0, down 45.35% year-over-year; the trailing twelve-month figure through Mar 2020 was $435000.0 (down 45.35% YoY), and the FY2019 annual result was $416000.0, changed N/A from the prior year.
- Current Leases improved to $435000.0 in Q1 2020 per FBRX's latest filing, from $416000.0 in the prior quarter.
- Over five years, Current Leases peaked at $876000.0 in Q3 2019 and troughed at $416000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 435,000.00 |
| Dec 31, 2019 | 416,000.00 |
| Sep 30, 2019 | 876,000.00 |
| Jun 30, 2019 | 836,000.00 |
| Mar 31, 2019 | 796,000.00 |